Skip to menu Skip to content Skip to footer

2023

Conference Publication

INTERVENTIONS FOR PREVENTING THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS

Stanley, Isabelle Kitty, Palmer, Suetonia, Mallett, Andrew, Johnston, Brydee and Tunnicliffe, David (2023). INTERVENTIONS FOR PREVENTING THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS. HOBOKEN: WILEY.

INTERVENTIONS FOR PREVENTING THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS

2023

Conference Publication

A post-hoc analysis of the CKD-FIX study analysing the association between metformin use and eGFR decline

Stanley, I., Viecelli, A., Johnson, D., Hawley, C., Mallett, A., Staatz, C. and Milanzi, E. (2023). A post-hoc analysis of the CKD-FIX study analysing the association between metformin use and eGFR decline. Australian and New Zealand Society of Nephrology Conference, Cairns, QLD, Australia, 22-24 October 2023. HOBOKEN: WILEY.

A post-hoc analysis of the CKD-FIX study analysing the association between metformin use and eGFR decline

2023

Conference Publication

A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials

Stanley, I., Palma, A., Viecelli, A., Johnson. D., Hawley, C., Staatz, C. and Mallett, A. (2023). A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials. Asian Pacific Society of Dialysis Access (APSDA) Conference, Cairns, QLD Australia, 22-24th October 2023. HOBOKEN: WILEY.

A Secondary Analysis of Concurrent use of Metformin and Tolvaptan in ADPKD Tolvaptan Trials